[
  {
    "question": "Patient unable to track with his eyes, so he has to shake his head to change his gaze. What is this called?",
    "option_a": "Oculomotor apraxia",
    "option_b": "Optic ataxia",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The inability to initiate or smoothly track eye movements, necessitating compensatory head movements to change gaze, is characteristic of oculomotor apraxia. This condition involves difficulty in ordering voluntary saccadic eye movements. Oculomotor apraxia is typically a disorder of the cortical control of eye movements, particularly affecting the mechanisms that initiate saccadic shifts. The brain\u2019s networks responsible for predicting and initiating eye movement are disrupted, and consequently, patients use head thrusts or shaking to compensate for their impaired ocular tracking. Patients with oculomotor apraxia have difficulty shifting their gaze rapidly between targets. Instead, they compensate by moving their head to help direct their gaze, which is often an adaptive strategy for overcoming the underlying deficit in initiating proper saccades. Differential diagnoses include disorders such as optic ataxia (characterized by misreaching under visual guidance) and other ocular motor dysfunctions like internuclear ophthalmoplegia. A detailed ocular motility examination, along with neuroimaging, can help distinguish oculomotor apraxia from these conditions. There is no definitive treatment for oculomotor apraxia, and management is typically supportive. Rehabilitation strategies aimed at improving compensatory mechanisms as well as occupational therapy to ease daily activities can be helpful. For individuals in special circumstances such as pregnancy or lactation, supportive therapies (e.g., vision therapy) are preferred over pharmacological interventions due to safety concerns. Option A (Oculomotor apraxia) is correct because the clinical description \u2013 an inability to generate smooth ocular tracking leading to compensatory head movements \u2013 perfectly fits this condition. Option B (Optic ataxia) is not correct because optic ataxia involves impaired visually guided reaching rather than initiating gaze shifts. 1. Oculomotor apraxia leads to compensatory head movements to overcome deficits in initiating saccadic eye shifts. 2. The condition is distinct from other ocular motor disorders due to its specific effect on saccade initiation. 3. Rehabilitation and compensatory strategies are the mainstays of management. Recent studies in ocular motor control emphasize the role of frontal and parietal eye fields in saccadic initiation. Although no curative therapy exists, emerging neuro-rehabilitation methods are being developed to help improve ocular motor function. Current guidelines stress supportive care and individualized rehabilitation strategies, especially in populations like pregnant or lactating women where medication use is limited.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario of a patient with a history of blurry vision and headache she has acne and is taking vit A, has papilledema, bmi: 35, MRI report: normal? Rx?",
    "option_a": "acetazolamide",
    "option_b": "prednisolone",
    "option_c": "Topamax",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "This case describes a patient with blurry vision, headache, papilledema, obesity (BMI 35), and a history of acne and high vitamin A intake. These features are classic for Idiopathic Intracranial Hypertension (IIH), also known as pseudotumor cerebri. IIH commonly affects obese women of childbearing age, and excess vitamin A has been identified as a potential precipitating factor. IIH is characterized by increased intracranial pressure with normal CSF composition and no detectable mass lesion on imaging. The underlying mechanism is believed to be impaired CSF absorption at the arachnoid granulations, possibly exacerbated by metabolic and hormonal factors related to obesity. Vitamin A toxicity can also increase CSF production or reduce its absorption, thereby contributing to the elevated pressure. Patients typically present with headaches, transient visual obscurations, and papilledema. The visual complaints arise from optic nerve swelling due to elevated intracranial pressure, which, if left untreated, may lead to permanent vision loss. The modified Dandy criteria are used for diagnosis. Key steps include ruling out other causes with neuroimaging (typically a normal MRI, as seen in this scenario) and then performing a lumbar puncture to document elevated opening pressure with normal CSF constituents. Differential diagnoses include space-occupying lesions (ruled out by a normal MRI), meningitis, and venous sinus thrombosis. The first-line management is weight loss combined with acetazolamide, a carbonic anhydrase inhibitor that reduces the production of cerebrospinal fluid. If there is a contraindication or intolerance, alternatives like furosemide or topiramate (which also has weight-loss benefits) may be considered. In pregnant or lactating women, acetazolamide is used with caution (typically category C), and the risk\u2013benefit ratio must be carefully evaluated. In refractory cases, surgical options including optic nerve sheath fenestration or CSF shunting might be necessary. Option A (acetazolamide) is correct as it is the mainstay of medical treatment in IIH. Option B (prednisolone) is not standard treatment and is generally reserved for inflammatory conditions. Option C (Topamax or topiramate) may have a role as a second-line agent that can help reduce CSF production and promote weight loss, but it is not considered first-line. 1) IIH is most common in obese women, and weight loss is a critical part of management. 2) Vitamin A excess is a recognized risk factor for IIH. 3) A normal MRI in the presence of papilledema and elevated BMI should prompt consideration of IIH. Recent guidelines continue to endorse acetazolamide as the initial treatment for IIH, with emerging evidence supporting the adjunctive use of weight-loss strategies and possibly topiramate for its dual benefit in reducing CSF production and aiding weight reduction.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Postpartum patient came with a history of headache, attached picture showing pachymeningeal enhancement, next?",
    "option_a": "Blood patch",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "This question involves a postpartum patient presenting with headache and imaging showing pachymeningeal enhancement. This picture is typical for a post-dural puncture headache (PDPH), a condition that may occur after epidural or spinal anesthesia due to CSF leak. PDPH results from a loss of cerebrospinal fluid volume after a dural puncture. The resultant drop in CSF pressure leads to traction on pain-sensitive intracranial structures, producing a headache that is typically postural in nature (worsening when upright and improving when supine). The pachymeningeal enhancement seen on imaging is due to compensatory dural venous engorgement and meningeal irritation. The typical presentation includes a severe headache that is positional, frequently occurring in postpartum women who have undergone neuraxial anesthesia. The headache can be accompanied by nausea, neck stiffness, and photophobia. Diagnosis is primarily clinical, reinforced by imaging findings such as pachymeningeal enhancement on MRI. Differential diagnoses include tension headache, migraine, and, rarely, meningitis; however, the postural nature and the history of recent dural puncture help distinguish PDPH. Initial management involves conservative measures: bed rest, adequate hydration, and caffeine. However, if symptoms persist beyond 24-48 hours or are severe, an epidural blood patch is recommended. The blood patch involves the injection of autologous blood into the epidural space to seal the dural tear. In postpartum patients, this procedure is considered safe and does not significantly affect lactation. Option A (Blood patch) is correct as it represents the definitive treatment when conservative measures fail. No other options were provided, but alternatives like caffeine and bed rest are first-line before proceeding to a blood patch if necessary. 1) A postural headache in a postpartum patient with recent neuraxial anesthesia is highly suggestive of a CSF leak. 2) Pachymeningeal enhancement on MRI supports the diagnosis of intracranial hypotension. 3) The epidural blood patch is highly effective and typically provides rapid relief. Recent research and clinical guidelines support early consideration of an epidural blood patch in cases where conservative management does not lead to symptomatic improvement, citing high success rates and low complication rates.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Ocular bobbing case (eyes fast downward then slowly return to its primary position), localization?",
    "option_a": "Pons",
    "option_b": "Medulla",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Ocular bobbing is an abnormal ocular motor phenomenon characterized by a rapid downward movement of the eyes followed by a slow return to the primary position. This clinical sign is used to help localize lesions within the brainstem. The ocular bobbing phenomenon is thought to result from disruption of the neural integrators and pathways that control vertical eye movements. Damage to the structures in the pons, particularly in the tegmentum, impairs the normal control of ocular movements, leading to the repetitive pattern observed. Clinically, ocular bobbing is most commonly seen in patients with severe brainstem lesions, especially in the pons. Its presence indicates significant neurologic injury and often appears in the context of coma or other critical conditions. The diagnosis is primarily clinical. Neuroimaging, especially MRI, is essential to localize the lesion more precisely. Differential diagnoses include other abnormal ocular movements such as ocular flutter and nystagmus, which involve different mechanisms and localizations within the brain. There is no specific treatment for ocular bobbing itself; instead, management is directed at the underlying cause (e.g., infarction, hemorrhage, or other pontine injury) using appropriate critical care measures. In cases where the lesion is secondary to treatable causes, addressing the underlying problem remains the priority. Option A (Pons) is correct because ocular bobbing has been most consistently linked with pontine lesions. Option B (Medulla) is incorrect as the classical localization for this sign is in the pons rather than the medulla. 1) Ocular bobbing is a key sign of pontine dysfunction. 2) It generally indicates a severe brainstem injury with a potentially poor prognosis. 3) Neuroimaging is essential for accurate lesion localization in patients exhibiting ocular bobbing. Current literature emphasizes the importance of clinical examination in conjunction with advanced neuroimaging to accurately localize brainstem lesions. Ongoing research into ocular motor control continues to refine our understanding of the precise pathways involved in ocular bobbing.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario of above 60-year-old patient with a 1-month history of blurry vision and headache, next?",
    "option_a": "ESR. (not complete Q but if it was case of GCA so answer true)",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "In patients over the age of 60 who present with a new-onset headache and blurry vision, one high-priority diagnosis is Giant Cell Arteritis (GCA). GCA is a vasculitis of large and medium-sized arteries, most classically involving the temporal artery, and it can have dire consequences such as irreversible vision loss. GCA is a T-cell mediated inflammatory disorder that leads to granulomatous inflammation of the arterial wall. This results in luminal narrowing and ischemia of tissues supplied by the affected arteries, including the optic nerve, which can cause visual disturbances. Patients with GCA typically present with new-onset headache, scalp tenderness, jaw claudication, and visual symptoms. The elderly population is most at risk, and the condition constitutes a medical emergency given the high risk of permanent vision loss if treatment is delayed. Initial evaluation includes inflammatory markers such as the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Additional diagnostic modalities may include temporal artery ultrasound and ultimately temporal artery biopsy for definitive diagnosis. Differential diagnoses include other causes of headache in the elderly such as migraine, tension headache, or intracranial neoplasms, but the systemic inflammatory signs help distinguish GCA. In suspected GCA, high-dose corticosteroids (e.g., prednisone) should be initiated immediately to reduce the risk of irreversible vision loss. While ESR is useful in establishing the inflammatory nature of the illness, treatment should not be delayed in the presence of strong clinical suspicion. In patients who are pregnant or lactating, corticosteroids are generally considered safe when the benefits outweigh the potential risks, though careful monitoring is needed given their systemic effects. Option A (ESR) is correct as an initial laboratory investigation in a patient suspected of having GCA. Although immediate initiation of steroids is critical in high-suspicion cases, checking the ESR (and CRP) helps support the diagnosis. Other options (not provided) would potentially include imaging or biopsy, but ESR remains a rapid and accessible initial test. 1) Always have a high index of suspicion for GCA in patients over 50 presenting with headache and visual disturbances. 2) Elevated inflammatory markers (ESR/CRP) support the diagnosis. 3) Prompt initiation of high-dose corticosteroids is essential to prevent permanent vision loss. Recent guidelines stress the urgency of treatment in suspected GCA, with an emphasis on early high-dose steroid therapy even before a confirmatory temporal artery biopsy. Recent studies also advocate for the use of ultrasound in the diagnostic workup, and while ESR remains a cornerstone laboratory test, CRP is now equally emphasized as a marker of systemic inflammation.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Post bariatric surgery patient came with nystagmus, ataxia, findings suggestive of Wernicke\u2019s encephalopathy, what\u2019s the cause?",
    "option_a": "Vit B1",
    "option_b": "Vit b12",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Wernicke\u2019s encephalopathy is an acute neuropsychiatric syndrome resulting from thiamine (vitamin B1) deficiency. It classically presents with a triad of mental status changes, ocular abnormalities (e.g., nystagmus, ophthalmoplegia), and ataxia. In patients post\u2010bariatric surgery, nutritional malabsorption predisposes them to vitamin deficiencies, particularly thiamine deficiency. Thiamine is an essential cofactor in carbohydrate metabolism. Deficiency leads to impaired cellular energy production, particularly in brain regions with high metabolic demands such as the mammillary bodies, thalamus, and periaqueductal area. This energy failure results in neuronal injury and cytotoxic edema, ultimately manifesting as the clinical features of Wernicke\u2019s encephalopathy. Post-bariatric surgery patients are at risk due to reduced intake and potential malabsorption. The development of nystagmus and ataxia in this setting should raise high suspicion for thiamine deficiency. If untreated, the condition can progress to irreversible damage (Korsakoff\u2019s syndrome), characterized by memory impairment and confabulation. The diagnosis is primarily clinical. Although thiamine levels can be measured, treatment should not be delayed for laboratory confirmation. Differential diagnoses include cerebellar infarct, demyelinating diseases, and intoxications, but the context (bariatric surgery and nutritional deficiency) along with the classic triad strongly favors Wernicke\u2019s encephalopathy. The first-line treatment is immediate administration of high-dose intravenous thiamine (e.g., 500 mg IV three times daily for 2\u20133 days, then tapered), followed by oral supplementation. Glucose should never be administered prior to or concurrently without thiamine, as it can exacerbate the condition. In pregnant or lactating women, thiamine supplementation is safe and essential to prevent fetal and neonatal neurological complications. Option A (Vit B1) is correct because thiamine deficiency is the underlying cause of Wernicke\u2019s encephalopathy. Option B (Vit B12) is incorrect as vitamin B12 deficiency typically presents with subacute combined degeneration of the spinal cord and peripheral neuropathy rather than the ocular and gait disturbances seen in Wernicke\u2019s encephalopathy. 1. Always administer thiamine before glucose in patients at risk to prevent precipitating Wernicke\u2019s encephalopathy. 2. Bariatric surgery patients should receive prophylactic thiamine supplementation. 3. Early recognition and treatment are critical to prevent permanent neurological deficits. Recent guidelines emphasize early thiamine replacement in high-risk groups, including bariatric surgery patients, and advocate for routine prophylactic supplementation to prevent neurological complications. Advances in imaging and biochemical markers are being explored to improve early diagnosis.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario in 22 Y/O male suggestive of right 4th nerve palsy, asked about the cause?",
    "option_a": "Pinealoma",
    "option_b": "Trauma",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Trochlear nerve (cranial nerve IV) palsy causes vertical diplopia and problems with downward gaze, owing to its role in innervating the superior oblique muscle. The nerve\u2019s long intracranial course makes it particularly susceptible to trauma. Trauma can cause stretching or contusion of the trochlear nerve along its slender and elongated course around the brainstem. This disruption results in impaired innervation of the superior oblique, leading to vertical diplopia and compensatory head tilt to minimize symptoms. In a 22-year-old male with clinical features suggestive of a fourth nerve palsy, a history of head trauma is highly relevant. Patients typically exhibit a compensatory head tilt away from the affected side to reduce diplopia and may report vertical misalignment of images. Diagnosis is established on clinical examination and history. High-resolution neuroimaging (MRI or CT) may be warranted to rule out other intracranial causes. Differential diagnoses include brainstem lesions (e.g., demyelination, infarction) and congenital fourth nerve palsy, but trauma is the most common cause in young adults. Most traumatic fourth nerve palsies are managed conservatively as many cases resolve spontaneously over time. Symptomatic treatment using prism glasses may be beneficial, and strabismus surgery is considered for persistent cases. In pregnant or lactating women, imaging and therapeutic interventions are approached with caution, favoring non-invasive monitoring when possible. Option A (Pinealoma) is less likely in this scenario, as pineal region tumors typically present with Parinaud syndrome and affect vertical gaze more diffusely rather than causing isolated cranial nerve IV deficits. Option B (Trauma) is correct given the demographic and clinical findings. 1. Traumatic injury is the most common cause of an isolated fourth nerve palsy in young adults. 2. Patients often adopt a compensatory head tilt to reduce diplopia. 3. A thorough history of trauma is critical in evaluating cranial neuropathies. Contemporary research supports trauma as the primary etiology for trochlear nerve palsy in younger populations, and current guidelines recommend conservative management initially, with surgical options reserved for refractory cases.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "78 YO female with bilateral headache, and face pain when she eats came with decrease vision in one eye what is the cause",
    "option_a": "Ischemic optic neuropathy due to short ciliary artery",
    "option_b": "Retinal artery occlusion.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The scenario described \u2014 an elderly female with headache, jaw claudication (facial pain when eating), and visual loss \u2014 is highly suggestive of giant cell arteritis (GCA). Ischemic optic neuropathy, especially anterior ischemic optic neuropathy (AION) due to involvement of the short posterior ciliary arteries, is a well-recognized complication of GCA. Giant cell arteritis is a granulomatous vasculitis affecting medium and large arteries, primarily in individuals over 50 years. Inflammation leads to luminal narrowing or occlusion of branches such as the short posterior ciliary arteries, resulting in ischemia of the optic nerve head and subsequent vision loss. The clinical presentation of a 78-year-old female with new-onset headache, jaw claudication, and diminished vision is classical for GCA. The involvement of the short ciliary arteries causing anterior ischemic optic neuropathy requires urgent recognition to prevent bilateral blindness. Diagnosis is based on a combination of clinical features, elevated inflammatory markers (ESR, CRP), and confirmatory temporal artery biopsy. Differential diagnoses include nonarteritic AION, ocular ischemic syndrome, and other vasculitides, but the presence of systemic symptoms and jaw claudication heavily favors GCA. Immediate high-dose corticosteroid therapy (e.g., Prednisone 1 mg/kg/day or even intravenous methylprednisolone in cases of visual impairment) is imperative to halt progression. Temporal artery biopsy should be performed once treatment is initiated. In pregnancy and lactation, corticosteroids are generally considered safe when benefits outweigh risks, with careful monitoring for potential side effects. Option A (Ischemic optic neuropathy due to short ciliary artery) is correct because it directly reflects the pathophysiological consequence of GCA affecting the ocular circulation. Option B (Retinal artery occlusion) is a less likely cause in the setting of systemic inflammatory symptoms and jaw claudication, which specifically point towards GCA-associated AION. 1. Giant cell arteritis should be suspected in any elderly patient presenting with new-onset headache, jaw claudication, and visual symptoms. 2. Rapid initiation of steroid therapy is key to preventing bilateral vision loss. 3. Elevated ESR and CRP are important supportive findings. Recent recommendations emphasize early corticosteroid intervention in suspected GCA to prevent irreversible visual loss. Advances in imaging, such as high-resolution ultrasound of the temporal arteries and PET scans, are increasingly aiding in the rapid diagnosis of this vasculitis.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Long scenario pt with trigeminal neuralgia there is involvement of V1 which artery is do vascular compression?",
    "option_a": "(Posterior cerebral artery) is incorrect because its anatomical course does not place it in close proximity to the trigeminal nerve entry zone. Option B (Superior cerebellar artery) is correct as it is the vessel most commonly implicated in causing neurovascular compression leading to trigeminal neuralgia, including when V1 is involved. Option C (Middle cerebral artery) is also incorrect due to its lateral and anterior course, making it an unlikely offender in this context.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Trigeminal neuralgia is characterized by sudden, severe, lancinating facial pain due to neurovascular compression of the trigeminal nerve at its root entry zone. Although the condition typically affects the maxillary (V2) and mandibular (V3) divisions, involvement of the ophthalmic division (V1) can occur depending on the site and severity of compression. Repeated pulsatile vascular compression of the trigeminal nerve (most often by a looping vessel) leads to segmental demyelination and aberrant electrical conduction. The superior cerebellar artery, due to its close proximity to the nerve's entry zone on the pons, frequently exerts this compressive force resulting in the characteristic neuralgic pain. Patients with trigeminal neuralgia complain of brief, shock-like pain episodes triggered by activities such as chewing or light touch. When V1 is involved, the pain may be felt in areas such as the forehead and around the eye. The identification of the offending vessel is crucial in planning potential surgical interventions. High-resolution MRI with specific sequences (e.g., FIESTA/CISS) is used to identify vascular contacts at the trigeminal nerve root. Differential diagnoses include secondary trigeminal neuralgia due to multiple sclerosis plaques or tumors, which are excluded with imaging and clinical correlation. First-line treatment consists of anticonvulsant therapy, with carbamazepine being the most commonly used agent. If medical management fails, surgical options like microvascular decompression are considered. In pregnant or lactating women, medication choices should be carefully assessed for teratogenic effects, with a careful risk-benefit analysis directing management strategies. Option A (Posterior cerebral artery) is incorrect because its anatomical course does not place it in close proximity to the trigeminal nerve entry zone. Option B (Superior cerebellar artery) is correct as it is the vessel most commonly implicated in causing neurovascular compression leading to trigeminal neuralgia, including when V1 is involved. Option C (Middle cerebral artery) is also incorrect due to its lateral and anterior course, making it an unlikely offender in this context. 1. The superior cerebellar artery is the classic culprit in neurovascular compression seen in trigeminal neuralgia. 2. High-quality MRI is essential for identifying the responsible vascular loop. 3. Microvascular decompression offers a potential curative option in refractory cases. Recent neuroimaging advancements have improved the identification of offending vessels in trigeminal neuralgia, and current guidelines support the use of carbamazepine as the first-line agent. For refractory cases, microvascular decompression remains the standard surgical treatment, with a growing body of evidence confirming its long-term efficacy.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Patient had history of pica infarction two years ago, came with vertical with tortional oscillation where is the lesion",
    "option_a": "Interstitial nucleus of cajal",
    "option_b": "Inferior cerebellar peduncle",
    "option_c": "Inferior olive",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The interstitial nucleus of Cajal (INC) acts as a neural integrator responsible for maintaining vertical and torsional gaze. Lesions here disrupt the ability to sustain stable vertical eye positions, leading to vertical-torsional oscillations. The INC, located in the rostral midbrain adjacent to other ocular motor structures, integrates signals required for vertical gaze holding. A lesion here interrupts the tonic innervation to vertical gaze centers, resulting in abnormal vertical movements with torsional components. Post-vascular events, such as strokes, can localize to this area, leading to these specific eye movement abnormalities. Patients with an INC lesion typically present with nystagmus that has vertical and torsional qualities. Although the patient had a PICA (Posterior Inferior Cerebellar Artery) infarction in the past \u2013 which usually affects the lateral medulla or cerebellum \u2013 the current presentation of vertical-torsional oscillation is more consistent with a midbrain lesion affecting the INC. The diagnosis relies on detailed neuroimaging, typically MRI of the brainstem, to isolate the lesion. Differential diagnoses include lesions of the rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF), which also affects vertical gaze, as well as cerebellar or inferior olive lesions. However, the distinctive pattern of vertical-torsional oscillation points toward the INC. Management involves addressing the underlying cause (e.g., vascular risk factor modification post-stroke) and symptomatic treatment of eye movement abnormalities. Therapeutic options include vestibular rehabilitation and medications such as gabapentin or memantine for nystagmus control. In pregnant or lactating patients, non-pharmacologic strategies and medications with proven safety profiles should be prioritized. Consultation with neuro-ophthalmology is recommended for targeted interventions. Option A (Interstitial nucleus of Cajal) is correct because it is directly involved in vertical and torsional gaze-holding. Option B (Inferior cerebellar peduncle) is more typically associated with cerebellar coordination, and Option C (Inferior olive) is known for its role in timing and tremors, not for vertical-torsional oscillations. Vertical-torsional oscillations point to a dysfunction in the neural integrator of vertical gaze, classically the interstitial nucleus of Cajal. Always consider brainstem lesions in patients presenting with such ocular findings. Accurate localization via MRI is crucial for guiding management. Recent studies and neuroimaging advancements continue to clarify the role of the INC in ocular motor control. Current guidelines advocate for a multidisciplinary approach that tailors symptomatic management while carefully considering contraindications in pregnant or lactating populations.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Patient has left MCA aneurysm underwent clipping, then had loss of left eye loss of vision fundoscopy showed no obvious retina more optic disc no RAPD, left eye showed mild hemorrhage (look like terson syndrome), where is the localization:",
    "option_a": "Virtuous hemorrhage",
    "option_b": "Optic nerve",
    "option_c": "Optic tract",
    "option_d": "Anterior calcarine cortex",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The case describes a patient who developed visual loss after undergoing clipping of a left MCA aneurysm. The fundoscopic findings reveal an inability to appreciate the retinal details, with only the optic disc being visible, and the presence of a mild hemorrhage resembling Terson syndrome. Terson syndrome is defined as vitreous hemorrhage associated with subarachnoid hemorrhage, where increased intracranial pressure leads to bleeding into the vitreous cavity. Elevated intracranial pressure, often due to an aneurysmal bleed, can be transmitted along the optic nerve sheath. This pressure transmission may cause rupture of the retinal vessels, resulting in vitreous hemorrhage. The hemorrhage obscures the retinal details without directly injuring the optic nerve, which explains the absence of a relative afferent pupillary defect (RAPD). Clinically, patients with vitreous hemorrhage present with sudden visual loss that may be mistaken for intraocular pathology. Fundoscopic examination typically shows blood in the vitreous, obscuring the retinal view while sparing the optic disc. The lack of RAPD differentiates it from optic nerve pathology. The diagnosis is primarily clinical, based on the history of aneurysmal clipping (with its potential for Terson syndrome), and confirmed on fundoscopic exam that reveals vitreous opacities. Ancillary imaging, such as ocular ultrasound, can be used if the fundus details are not visible. Differential diagnoses include optic nerve injury, optic tract lesions, or cortical visual pathway damage, all of which would present with additional signs such as RAPD or specific visual field deficits. Management of vitreous hemorrhage in the context of Terson syndrome is usually conservative initially, as many hemorrhages resolve spontaneously. If visual impairment persists, especially if the hemorrhage does not clear over time, a vitrectomy may be considered. In patients who are pregnant or lactating, careful consideration is needed regarding anesthesia, surgical timing, and exposure to any agents that might affect the fetus or infant. The latest guidelines recommend close observation and intervention only if significant vision-threatening sequelae occur. Option A (Virtuous hemorrhage) is interpreted as a misprint or alternative term for vitreous hemorrhage, which correctly localizes the lesion in Terson syndrome. Option B (Optic nerve) would typically present with a RAPD if injured. Option C (Optic tract) would lead to contralateral homonymous visual field deficits, and Option D (Anterior calcarine cortex) would lead to specific homonymous hemianopia without fundoscopic hemorrhage. 1. Terson syndrome is a known complication of subarachnoid hemorrhage and aneurysmal clipping. 2. The absence of a RAPD in this context supports an intraocular cause rather than optic nerve pathology. 3. Vitreous hemorrhage can obscure retinal details on fundoscopy, distinguishing it from other visual pathway lesions. Current evidence supports the role of conservative management for vitreous hemorrhage associated with Terson syndrome, with vitrectomy reserved for non-clearing hemorrhages or when significant visual impairment persists. In pregnancy and lactation, decisions must balance maternal benefits with fetal/infant safety, following guidelines that minimize exposure to harmful agents and radiation.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "What support central nystagmus rather than peripheral nystagmus?",
    "option_a": "Absence of latency",
    "option_b": "sever nausea and vomiting",
    "option_c": "disappear and loss with visual fixation \u0645\u0648 \u0645\u062a\u0627\u0643\u062f\u0629 \u0645\u0646 \u0646\u0635 \u0647\u0627\u0644\u0627\u062e\u062a\u064a",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Nystagmus can originate from either peripheral vestibular structures or central nervous system regions (brainstem and cerebellum). One key clinical distinction is that central nystagmus typically appears immediately (i.e., without a latency period) when provoked, while peripheral nystagmus (e.g., in BPPV) usually exhibits a short latency and is often suppressed by visual fixation. Central nystagmus arises from lesions in the brainstem or cerebellum that disrupt the normal neural integration of ocular motor signals. This disruption leads to unmodulated and often multidirectional nystagmus. In contrast, peripheral lesions (such as those affecting the otolith organs or semicircular canals) produce nystagmus with a delayed onset, fatigability, and suppression by fixation due to the intact central inhibitory mechanisms. Patients with central lesions may exhibit nystagmus along with other neurological deficits (e.g., dysmetria, ataxia, or diplopia). The immediate onset of nystagmus without latency should raise clinical suspicion for a central cause, distinguishing it from benign peripheral disorders like BPPV, which characteristically have a latency period before nystagmus onset. A detailed neurological and vestibular examination is warranted when nystagmus is noted. Key differentiators include immediate onset (absence of latency) and lack of suppression by visual fixation in central nystagmus. Neuroimaging studies (MRI preferred) are indicated when a central cause is suspected. In pregnant or lactating patients, MRI without contrast is generally considered safe, and imaging should be pursued if clinical suspicion is high. When central nystagmus is suspected, timely neuroimaging and neurological consultation are essential to identify the underlying cause, such as stroke, demyelinating disease, or tumor. Management decisions must consider patient-specific factors, including pregnancy and lactation. In these groups, MRI is typically preferred over CT to avoid radiation exposure, and contrast use is minimized unless the benefits outweigh the risks. Option A (\u2018Absence of latency\u2019) is a feature consistent with central nystagmus because such nystagmus appears immediately upon provocation. Option B (\u2018sever nausea and vomiting\u2019) is more indicative of a peripheral vestibular disorder, where intense vertigo and autonomic symptoms are common. Option C (\u2018disappear and loss with visual fixation\u2019) is characteristic of peripheral nystagmus, as central nystagmus typically persists despite visual fixation. Option D is not provided. \u2022 Central nystagmus typically presents immediately without a latency period and is not suppressed by visual fixation. \n\u2022 Always consider central pathology in the absence of latency, particularly if accompanied by other neurological deficits. \n\u2022 In scenarios where central pathology is suspected, especially in high-risk groups like pregnant or lactating patients, timely and appropriate neuroimaging is crucial. Recent studies and clinical guidelines reinforce that the absence of latency is a critical indicator of central nystagmus. The differentiation between central and peripheral nystagmus using temporal characteristics (immediate onset versus delayed onset with latency) and response to visual fixation is supported by current vestibular and neuro-ophthalmologic research.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "pt had left eye heterotropia and skew, pt tilt to the rt where is the lesion?",
    "option_a": "left midbrain",
    "option_b": "Rt midbrain",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The ocular tilt reaction (OTR) is a clinical syndrome characterized by skew deviation (vertical misalignment of the eyes), ocular torsion, and a compensatory head tilt. In central (brainstem) lesions, particularly those affecting the vestibular otolith pathways in the midbrain (e.g., the interstitial nucleus of Cajal), the head tilt is typically contraversive\u2014that is, it tilts away from the side of the lesion. The integration of graviceptive (otolithic) signals occurs in the midbrain, particularly via the interstitial nucleus of Cajal, which is crucial for vertical gaze stabilization and ocular counterrolling. A unilateral lesion in the left midbrain disrupts the balance of these signals. This imbalance leads to a left eye heterotropia (skew deviation, with the left eye deviating vertically) and a compensatory head tilt to the right side (contraversive head tilt), as the brain attempts to correct for the perceived abnormal head position. Patients with brainstem lesions often exhibit subtle oculomotor signs before more overt neurological deficits appear. Here, the presence of a left eye skew (heterotropia) with a head tilt to the right is strongly suggestive of a central etiology, specifically a lesion in the left midbrain. Such findings alert the clinician to consider a stroke or other structural lesion in the brainstem rather than a peripheral vestibular disorder, which typically causes an ipsiversive (same-side) head tilt. The differential diagnosis includes peripheral vestibular disorders (e.g., vestibular neuritis), which generally present with an ipsiversive head tilt (tilting toward the side of the lesion), and other brainstem pathologies such as lateral medullary syndrome. Neuroimaging, particularly an MRI of the brain, is critical to localize the lesion accurately. In pregnant or lactating patients, MRI without gadolinium contrast is recommended for safety, ensuring accurate diagnosis without harm. Once a central brainstem lesion is suspected based on clinical signs, prompt neuroimaging is mandatory to confirm the diagnosis and rule out an ischemic event or other pathology. Management follows established stroke or brainstem lesion protocols (including antithrombotics, blood pressure management, etc.). In pregnancy or lactation, clinicians must select imaging (MRI without contrast) and treatment options that balance maternal benefit with fetal safety, per the latest guidelines. Option A (left midbrain) is the best match: a lesion in the left midbrain typically produces a contraversive head tilt (to the right) along with ipsilesional skew deviation (the left eye deviates). Option B (right midbrain) would more likely cause a head tilt to the left, which is not the case here. The absence of further details for options C and D reinforces the selection of Option A. \u2022 Ocular tilt reaction is a key localizing sign in brainstem pathology.  \u2022 In central lesions (midbrain), the head tilt is typically contraversive (away from the lesion).  \u2022 A combination of skew deviation and head tilt should prompt urgent neuroimaging.  \u2022 Consider pregnancy/lactation safe imaging (noncontrast MRI) when appropriate. Recent research supports the reliability of the ocular tilt reaction in differentiating central from peripheral vestibular disorders. MRI remains the gold standard for diagnosis. In addition, current guidelines emphasize tailored management especially in populations such as pregnant or lactating women, where imaging and treatment protocols are adapted to minimize fetal risk while effectively addressing maternal neurological emergencies.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "pt came with rt optic atrophy and left papilledema where is the localization of the mass ?",
    "option_a": "left frontal",
    "option_b": "Rt frontal",
    "option_c": "Left occipital",
    "option_d": "Rt occipital",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "This question is based on the classic description of Foster Kennedy syndrome. In this syndrome, a mass\u2014most commonly an olfactory groove meningioma\u2014compresses the optic nerve on one side, leading to ipsilateral optic atrophy, while increased intracranial pressure produces papilledema in the contralateral eye. A frontal lobe mass (often in the olfactory groove region) directly compresses the optic nerve on the same side, causing degeneration (optic atrophy) over time. The mass also increases intracranial pressure, which secondarily induces papilledema in the opposite eye. This combination of unilateral atrophy and contralateral disc swelling is pathognomonic for Foster Kennedy syndrome. Patients frequently present with progressive visual loss on the side of the optic nerve compression, along with signs of raised intracranial pressure. Some may also have anosmia or personality changes if the frontal lobe is involved. The unilateral optic atrophy coupled with contralateral papilledema should prompt consideration of a frontal mass. Once Foster Kennedy syndrome is suspected, neuroimaging studies (preferably MRI with contrast) are indicated to identify a frontal lobe mass. Differential diagnoses include other causes of unilateral optic nerve damage (such as optic neuritis) or bilateral papilledema from idiopathic intracranial hypertension, but the asymmetric findings help differentiate it. The primary management is directed toward the underlying intracranial mass. First-line treatment generally involves neurosurgical resection of the tumor. Adjunctive therapies (such as corticosteroids) may be used to manage cerebral edema. In pregnancy or lactation, multidisciplinary team management is crucial; neurosurgical intervention should minimize fetal exposure to anesthesia and other perioperative risks, and steroids should be used judiciously with fetal safety in mind. Option A (left frontal) is incorrect because the syndrome classically localizes to the side of optic nerve compression (right side in this case). Options C and D (occipital locations) are not associated with the combination of ipsilateral optic atrophy and contralateral papilledema. Option B (right frontal) is correct as it aligns with the typical location for an olfactory groove meningioma causing these findings. 1. Foster Kennedy syndrome is characterized by ipsilateral optic nerve atrophy and contralateral papilledema. 2. An olfactory groove meningioma is the prototype lesion responsible for this syndrome. Recent advances in high-resolution neuroimaging have improved the detection and characterization of frontal lobe tumors. Current guidelines emphasize early surgical intervention for symptomatic meningiomas, with special considerations in pregnant patients to balance maternal and fetal risks.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "A 44-year-old man is evaluated for visual loss. Examination shows a right homonymous hemianopia with a relative afferent pupillary defect in the right eye. Which of the following is the most likely location of the lesion?",
    "option_a": "junction between left optic nerve and chiasm",
    "option_b": "lateral fibers of the right optic nerve",
    "option_c": "left lateral geniculate nucleus",
    "option_d": "left occipital cortex",
    "option_e": "left optic tract",
    "correct_answer": "E",
    "subspecialty": "Neuroophthalmology",
    "explanation": "This question revolves around the localization of lesions in the visual pathways. Post-chiasmal lesions produce contralateral homonymous hemianopia, and in some cases, particularly with optic tract lesions, a relative afferent pupillary defect (RAPD) can be seen in the eye contributing a larger portion of the affected fibers. The left optic tract contains fibers from the right temporal retina and left nasal retina, which together encode the right visual hemifield. Damage to the left optic tract not only produces right homonymous hemianopia but, because of the slight asymmetry (with the temporal fibers being slightly more abundant), may result in a subtle RAPD in the right eye. Patients with optic tract lesions typically present with loss of the same visual half-field in each eye (homonymous hemianopia). The presence of a RAPD in the right eye, though subtle, fits with the asymmetry in fiber contribution, aiding in lesion localization. The differential includes lesions at various post-chiasmal locations such as the lateral geniculate body, optic radiations, and occipital cortex. Detailed visual field testing, assessment of pupillary responses, and brain MRI are used to distinguish between these. Occipital lesions, for instance, often spare pupillary responses because of dual blood supply and macular sparing. Management is directed by the underlying cause of the lesion (e.g., vascular event, demyelination, neoplasm). Acute management of a stroke affecting the optic tract might involve thrombolytic therapy if within a time window. In neoplastic cases, neurosurgical intervention is considered. In pregnant or lactating patients, treatments such as thrombolytics or surgery are planned with multidisciplinary input to ensure maternal and fetal safety. Option A (junction between left optic nerve and chiasm) would produce a junctional scotoma and different visual field defects. Option B (lateral fibers of right optic nerve) would affect only one eye. Option C (left lateral geniculate nucleus) and Option D (left occipital cortex) are possible sites of post-chiasmal lesions but typically do not produce a noticeable RAPD because the pupillary light reflex pathways have redundancy. Option E (left optic tract) best explains the right homonymous hemianopia with a relative afferent defect (notably in the right eye) because of the differential fiber contribution. 1. Homonymous hemianopia localizes the lesion to post-chiasmal pathways. 2. A mild RAPD may be present in optic tract lesions despite their post-chiasmal location. Modern neuro-ophthalmology emphasizes the use of detailed visual field analysis and high-resolution MRI to accurately localize lesions. Current research supports the concept that even modest asymmetries in fiber contribution in the optic tract can result in a clinically detectable RAPD.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Most common cause of 4th CN palsy",
    "option_a": "(Congenital) is common but frequently remains undiagnosed and asymptomatic until later in life when decompensation occurs, making it less often the cause of symptomatic presentations. Option B (Trauma) is correct because trauma is typically the most common cause of a clinically significant fourth nerve palsy in symptomatic patients. Option C (Microvascular) occurs predominantly in older patients with vascular risk factors and is less frequent compared to trauma in a broader population.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "b",
    "subspecialty": "Neuroophthalmology",
    "explanation": "This question concerns the etiology of fourth cranial nerve (trochlear nerve) palsy. Although multiple etiologies exist\u2014including congenital, traumatic, and microvascular origins\u2014the clinical presentations often guide identification of the most common cause in a symptomatic population. The trochlear nerve, due to its long intracranial course and decussation, is particularly vulnerable to traumatic injury. When subjected to shearing forces from head trauma, the delicate fibers of the nerve are often injured, resulting in vertical diplopia and compensatory head tilt. Patients with fourth nerve palsy typically present with vertical diplopia, which worsens on looking down (such as when reading or descending stairs), and often adopt a head tilt to compensate for the misalignment. A history of head trauma is a key feature pointing towards a traumatic etiology. The differential diagnosis for fourth nerve palsy includes congenital palsy (which may be asymptomatic until decompensation occurs) and microvascular ischemia (commonly seen in older individuals with vascular risk factors such as diabetes and hypertension). A careful history emphasizing trauma is critical. Neuroimaging may be warranted if trauma or other compressive lesions are suspected. Initial management of traumatic fourth nerve palsy typically involves conservative observation, as many cases partially recover spontaneously. Prism therapy and, in persistent cases, strabismus surgery may be considered. In patients with suspected microvascular palsy, control of underlying vascular risk factors is imperative. For pregnant or lactating patients, conservative management is preferred to avoid unnecessary exposure to surgical risks or medications, unless the underlying cause dictates otherwise. Option A (Congenital) is common but frequently remains undiagnosed and asymptomatic until later in life when decompensation occurs, making it less often the cause of symptomatic presentations. Option B (Trauma) is correct because trauma is typically the most common cause of a clinically significant fourth nerve palsy in symptomatic patients. Option C (Microvascular) occurs predominantly in older patients with vascular risk factors and is less frequent compared to trauma in a broader population. 1. Patients with fourth nerve palsy often compensate with a head tilt to reduce diplopia. 2. A history of head trauma is a critical clue in establishing the diagnosis of traumatic fourth nerve palsy. Recent studies continue to support trauma as the leading cause of symptomatic fourth nerve palsy, particularly in younger populations. Advances in imaging have also improved the recognition of microstructural changes in the nerve following trauma.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Which of the following is the most common presentation of GCA",
    "option_a": "(AION) is correct because it represents the most common ophthalmic manifestation of GCA. Other potential presentations such as central retinal artery occlusion, posterior ischemic optic neuropathy, or optic neuritis are less common in the context of GCA and do not typically present with the same clinical constellation as AION.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Giant cell arteritis (GCA) is a systemic vasculitis that mainly affects medium to large arteries. The neuro-ophthalmic complications, particularly anterior ischemic optic neuropathy (AION), are the most common presentations due to the involvement of the posterior ciliary arteries supplying the optic nerve head. In GCA, inflammatory granulomatous changes in the arterial wall lead to luminal narrowing and occlusion. When the posterior ciliary arteries are involved, the ischemia of the optic nerve head occurs, most commonly manifesting as AION. This ischemic process results in sudden, painless vision loss. Patients with GCA generally present in the elderly with systemic symptoms such as headache, jaw claudication, and scalp tenderness alongside visual disturbances. The classic finding is sudden, painless visual loss with optic disc edema (which may evolve to optic atrophy if untreated). The differential diagnosis includes non-arteritic AION, which is more common in patients with vascular risk factors, and other causes of optic neuropathy like optic neuritis (typically painful and seen in younger patients). Laboratory evaluation with elevated ESR and CRP, along with temporal artery biopsy, are critical for confirming the diagnosis of GCA. Immediate treatment with high-dose corticosteroids is the mainstay of therapy to prevent further visual loss and involvement of the contralateral eye. The standard approach is to begin steroids immediately upon suspicion, even before the temporal artery biopsy is performed. In pregnant or lactating patients, corticosteroids remain the first-line therapy, with careful monitoring given the potential maternal and fetal side effects. Newer agents like tocilizumab may be considered as steroid-sparing measures in certain cases. Option A (AION) is correct because it represents the most common ophthalmic manifestation of GCA. Other potential presentations such as central retinal artery occlusion, posterior ischemic optic neuropathy, or optic neuritis are less common in the context of GCA and do not typically present with the same clinical constellation as AION. 1. High-dose corticosteroid therapy should be initiated immediately if GCA is suspected, to prevent irreversible vision loss. 2. AION is the most common neuro-ophthalmic presentation in GCA and is a true ophthalmic emergency. Recent guidelines reinforce the critical importance of prompt steroid treatment in suspected GCA. Studies have also highlighted the utility of high-resolution ultrasound of the temporal arteries as an emerging diagnostic tool that may supplement or even partially replace temporal artery biopsy in selected cases.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Which of the following has large effect of RAPD (I think they mean more RAPD)",
    "option_a": "(optic nerve) is correct because it directly affects the afferent pathway leading to a significant RAPD. Option b (retina) usually requires extensive damage to elicit a marked RAPD, option c (optic tract) is a post",
    "option_b": "",
    "option_c": "",
    "option_d": "(lateral geniculate nucleus) is similarly post",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuroophthalmology",
    "explanation": "A relative afferent pupillary defect (RAPD) occurs when there is an asymmetry in the afferent limb of the pupillary light reflex. The optic nerve, being the primary conduit of retinal signals to the brain, when damaged, creates a marked defect in the afferent input, leading to a pronounced RAPD. Lesions of the optic nerve (as in optic neuritis, ischemic optic neuropathy, or compressive lesions) disrupt the normal conduction of visual signals. This results in a reduced afferent drive when light is shone in the affected eye, thereby causing less pupillary constriction compared to the normal eye. The imbalance is easily detected during the swinging flashlight test. Patients with optic nerve pathology often present with decreased visual acuity, color vision deficits, and sometimes pain on eye movement. The clear presence of a marked RAPD on examination helps localize the lesion to the pre-chiasmal portion of the visual pathway. Differential diagnoses include extensive retinal disease (e.g., severe retinal artery occlusion) which can rarely produce an RAPD if a large area is affected, but typically an optic nerve lesion is implicated. Ancillary tests such as visual field testing, optical coherence tomography (OCT), and MRI (in suspected optic neuritis) help refine the diagnosis. Management varies with the underlying cause. For example, in optic neuritis associated with multiple sclerosis, high-dose intravenous corticosteroids are first-line therapy (with careful obstetric consultation in pregnant or lactating patients, as steroids are generally used with caution and after risk-benefit analysis). Ischemic optic neuropathy may require cardiovascular risk factor modification. Early diagnosis is crucial to prevent further vision loss. Option a (optic nerve) is correct because it directly affects the afferent pathway leading to a significant RAPD. Option b (retina) usually requires extensive damage to elicit a marked RAPD, option c (optic tract) is a post-chiasmal structure with partial bilateral representation, and option d (lateral geniculate nucleus) is similarly post-chiasmal; neither typically produce a large RAPD. 1. A marked RAPD is classically seen in optic nerve lesions rather than isolated retinal conditions. 2. The swinging flashlight test remains a vital bedside tool for localizing lesions in the visual pathway. 3. Early detection of an optic neuropathy can be critical in diseases like multiple sclerosis. Recent guidelines emphasize the use of OCT and MRI in the evaluation of optic nerve disorders. Studies continue to support that the magnitude of RAPD correlates with the degree of optic nerve dysfunction, thereby guiding both diagnosis and management.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Clinical feature suggesto of rt MLF where is the lesion (impaired rt eye adduction, with left eye nystagmus on abduction)",
    "option_a": "(Rt MLF) is correct as the lesion in the right MLF leads to the specific pattern of impaired right eye adduction with contralateral abducting nystagmus. Alternative options such as lesions in the right abducens nucleus or oculomotor nerve are inconsistent with the clinical picture provided.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Internuclear ophthalmoplegia (INO) results from a lesion in the medial longitudinal fasciculus (MLF), a tract that coordinates horizontal eye movements by linking the abducens nucleus to the contralateral oculomotor nucleus. A lesion in the right MLF disrupts the signal from the left abducens nucleus to the right oculomotor nucleus. This results in impaired adduction of the right eye during horizontal gaze, while the abducting left eye experiences nystagmus due to overcompensation. Clinically, patients with a right INO will present with diplopia and difficulty in adducting the right eye, along with the presence of abducting nystagmus in the left eye. In young patients, multiple sclerosis is a common cause, while in older adults, vascular causes may be implicated. The diagnosis is primarily clinical but may be supported by MRI which typically shows demyelinating plaques in cases of multiple sclerosis. Differential diagnoses include cranial nerve III palsy (which would also have ptosis and pupillary involvement) and myasthenia gravis (which tends to have variable weakness without consistent findings on neuroimaging). The underlying cause of INO guides management. In multiple sclerosis, high-dose steroids and disease-modifying agents are the mainstay, with careful consideration of medication safety in pregnancy and lactation. In vascular causes, management of risk factors such as hypertension and diabetes is appropriate. Option a (Rt MLF) is correct as the lesion in the right MLF leads to the specific pattern of impaired right eye adduction with contralateral abducting nystagmus. Alternative options such as lesions in the right abducens nucleus or oculomotor nerve are inconsistent with the clinical picture provided. 1. INO is characterized by dissociated horizontal gaze, where the affected eye fails to adduct while the contralateral abducting eye exhibits nystagmus. 2. Multiple sclerosis is a leading cause of INO in young adults. 3. The clinical findings in INO help localize the lesion to the MLF even before imaging is performed. Latest clinical guidelines emphasize early MRI in suspected demyelinating disease. New therapeutic agents for MS are continuously being evaluated, and clinical trials are refining management strategies for acute INO.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Hallucination where is the lesion",
    "option_a": "(Midbrain",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Visual hallucinations can be due to lesions in various parts of the brain. Peduncular hallucinosis refers to vivid, well-formed visual hallucinations that are typically associated with lesions of the midbrain, particularly in the peduncular region. Lesions in the midbrain disrupt central inhibitory circuits that normally modulate visual perception. This disruption can lead to a release phenomenon where complex, formed visual hallucinations emerge despite preserved primary visual processing. Patients with peduncular hallucinosis often report seeing detailed and sometimes bizarre images while retaining insight into the hallucinations. These hallucinations differ from simpler visual phenomena seen in occipital lobe lesions. Diagnosis involves neuroimaging (typically MRI) to identify potential midbrain lesions. Differential diagnoses include occipital lobe lesions (which tend to produce simpler visual hallucinations and may be associated with visual field deficits), temporal lobe epilepsy (which often presents with brief stereotyped hallucinations), and psychiatric conditions (which more commonly involve auditory hallucinations). Management focuses on treating the underlying lesion. In some cases, antipsychotic medication may be used if hallucinations are distressing; however, caution is advised in pregnant or lactating patients, where the risk-benefit ratio of antipsychotic use must be carefully analyzed. Neurosurgical consultation might be necessary if a focal lesion is amenable to intervention. Option a (Midbrain \u2013 Peduncular hallucinosis) is correct. Occipital lobe lesions tend to cause simpler visual hallucinations, whereas lesions in other areas like the temporal or parietal lobes do not consistently produce the complex hallucinations seen in peduncular hallucinosis. 1. Peduncular hallucinosis is characterized by vivid, dream-like visual hallucinations with maintained insight. 2. It is typically linked to midbrain lesions rather than primary cortical pathology. 3. Recognizing the pattern helps distinguish it from other causes of visual hallucinations. Recent research supports that peduncular hallucinosis is associated with midbrain pathology, with improved neuroimaging techniques allowing for better characterization of the lesions. Updated guidelines highlight the importance of correlating clinical findings with imaging to rule out other etiologies such as seizures or psychiatric disorders.",
    "exam_year": "2022",
    "exam_type": "Part I"
  }
]